-
Retail pharmacy chemical drug "iron triangle" easy to master! Vitamin and mineral supplements become "explosive...
Time of Update: 2021-03-08
of hospital procurement is also high, so the first three batches of centralized procurement of the state contains drugs for this type of disease. The first batch of medicines contained lipid-lowering drugs (atovastatin calcium tablets/rishuvastatin
-
The phase III drug study of Psoriasis in BMS met the standard
Time of Update: 2021-03-06
POETYK PSO-1 is the first of two global III studies to assess the safety and effectiveness of deucravacitinib in patients with moderate to severe plaque-like psoriasis compared to placebo and Otezla .
-
Medici partner Shengnoki "first-in-class" new drug up to III
Time of Update: 2021-03-06
receptor (estrogen receptor, ER) has inhibition activity, since then, for masturbation amniotic acid in the pharmaceutical aspects of research has been carried out. Current studies of Acolatin's anti-tumor mechanisms have shown that it regulates
-
New anti-inflammatory drugs! AbbVie IL-23 inhibitor Skyrizi's treatment of Crohn's disease (CD) 2 Phase III induction studies have been successful!
Time of Update: 2021-03-06
, clinical remission was measured by CDAI (Crohn's Disease Activity Index) and PRO-2 (two-part patient reporting results). in the ADVANCE study, there was a significant increase in the proportion of patients treated with 600 mg or 1200 mg Skyrizi
-
AstraZenecom's Dagrid Net DAPA-CKD III study
Time of Update: 2021-03-06
, but also on the basis of diet and exercise to treat people with type 2 diabetes with poor blood sugar control, as well as weight loss and the additional benefits of blood pressure reduction and blood pressure reduction. DECLARE-TIMI 58 Cardiovascular
-
Wujiang three paint workers iron box operation deep poisoning coma
Time of Update: 2021-03-06
China Paint Network : "Thank you for winning valuable time for rescue, if a few minutes later, they will certainly be hopeless, really thank you!" "Recently, the police at Pingwang police station in Wujiang District, Suzhou, risked
-
Suzhou Xinxu Pharmaceutical tau protein PET tracer clinical phase III trial was approved and started
Time of Update: 2021-03-06
trial of Xinxu's tau protein PET tracer 18F-APN-1607, marking a further step forward in Xinxu Pharmaceutical's goal of making neurodegenerative diseases, including Alzheimer's disease, more accurately diagnosed at an early date with non-invasive
-
Junshi Ripley single resistance was approved for Phase III clinical overlay by fda fast track eligibility overlay
Time of Update: 2021-03-05
treatment in patients with mucosal melanoma was also approved by the FDA. The first approved domestic PD-1 single anti-2018 December 2018, Junshi biotrepri single anti-injection in china obtained the conditional approval of NMPA listing
-
Novar3/Incyte launches jakafi Phase II Covid-19 Phase III clinical trial
Time of Update: 2021-03-03
diseases such as GVHD, Novartic and Incyte believe That Jakafi has the potential to allow COVID-19 patients to recover faster and reduce the need for intensive care and mechanical breathing. In addition, Roche's IL-6 inhibitors
-
AbbVie Skyrizi head-to-head Phase III study beats Novaral Cosentyx
Time of Update: 2021-03-03
This multi-center, randomized, open-label, efficacy evaluator-blind, positive drug-controlled study was conducted in adult patients with moderate to severe plaque psoriasis suitable for systematic treatment, comparing the safety and effectiveness of Skyrizi and Cosentyx.
-
The study on the treatment of chronic kidney disease iii in Dagle net was successfully terminated early
Time of Update: 2021-03-03
On September 16, 2019, the FDA granted Dagly net fast track eligibility to delay progression in renal failure and prevent cardiovascular and kidney death risk in patients with chronic kidney disease.
-
K drug small cell lung cancer PHASE III clinical reach PFS endpoint miss OS endpoint
Time of Update: 2021-03-03
results. The results showed that the Keytruda chemotherapy combination achieved a significant increase in the primary endpoint of patients' progress-free survival (PFS) (HR=0.75,95% CI, 0.61-0.91), but missed the primary endpoint of total lifetime (OS
-
All four trials of the No. and Nord agitant Weight Loss Phase III STEP project were successful
Time of Update: 2021-03-02
with type 2 diabetes (T2D) and obesity/overweight; The results showed that a weekly dose of semaglutide of 2.4 mg of semaglutide resulted in a statistically significant reduction in body weight compared to comfort.
-
The U.S. will advance Phase III clinical trials of three new crown-candidate vaccines
Time of Update: 2021-03-02
. Government will fund phase III clinical trials of three new coronavirus candidate vaccines, said Anthony Fucci, director of the National Institute of Allergy and Infectious Diseases and a key member of the White House Coronavirus
-
Immunomedics' ADC drug Triple Negative Breast Cancer III was successful
Time of Update: 2021-02-28
April 6, Immunomedics announced the early termination of its Phase III ASCENT study on the treatment of metastasis triple-negative breast cancer (TNBC) with its ADC drug sacituzumab govitecan, as recommended by the Independent Data Monitoring Board.
-
Why phase III clinical trials of the new crown vaccine are critical
Time of Update: 2021-02-25
for Disease Control and Prevention, accepted an exclusive interview with a reporter from Science and Technology Daily, he made an image of the example, the vaccine is the same, only soon after the development, do not take the "three ignorant real fire
-
The ground-breaking PCSK9-targeted RNAi drug inclisiran III was successfully studied
Time of Update: 2021-02-24
This is the second of three key Phase III clinical studies (ORION-9, ORION-10, ORION-11) of the drug, which showed that 300mg inclisiran was given 2 subsurfic injections a year, reaching all major and secondary endpoints, with good tolerance and safety.
-
Phase III clinical trials for the treatment of COVID-19 have been approved in the UK
Time of Update: 2021-02-24
/> the main purpose of this study was to compare the advantages of Aplidin (plitidepsin) at two dose levels (1.5 or 2.5 mg) over standard care. endpoint indicator is the percentage of patients who fully recover on ± day (1).
-
The AstraZeneca/Amtezepelumab Phase III asthma trial reached its main end point
Time of Update: 2021-02-24
Recently, the phase 3 trial of the drug tezepelumab, a partnership between Amjin and AstraZeneca, in patients with severe asthma, reached its main destination. compared to placebo plus standard treatment, the average annual acute asthma attack
-
Yantai Municipal Market Supervision And Administration publicly exposed 6 cases of food administrative punishment (III)
Time of Update: 2021-02-24
. issued a test report, the company produced cellar Chixia pearl dry red wine alcohol test conclusions are not qualified. the above-mentioned violations of the Company violate the provisions of Article 71,3 of the Food Safety Law
